In the fast-paced world of investing, the emergence of innovative tools can dramatically change how investors approach the ...

Dr. Drew Ramsey has been a psychiatrist for over 20 years, and he’s consistently found throughout his neuroscience research ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

According to scientists, wolves raised by humans cooperate as well with their caretakers as pet dogs do. This suggests that ...

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus ...

Child care is becoming increasingly unaffordable for working families in New Jersey, forcing some parents to spend 20% to 30% ...

"Read our 2025 review of VertiFree to find out if it can truly reduce dizziness and improve stability. We examine the pros ...

It’s best known as a slightly faddy route to weight loss, but could the ketogenic (keto) diet, high in proteins and fats and ...

Here's what registered dietitians want you to know about a new diet plan that could improve your heart health in 12 weeks and ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's diseaseSimufilam continued to dem ...

Intech Investment Management LLC boosted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 99.3% in the 4th quarter, according to its most recent disclosure with the ...